[
  {
    "ts": null,
    "headline": "FDA willing to trade faster drug reviews for lower prices, Bloomberg reports",
    "summary": "FDA Commissioner Marty Makary said the agency may fast-track new drugs from pharmaceutical companies that “equalize” the cost of their medicines between the U.S. and other countries, Bloomberg’s Rachel Cohrs Zhang and Sam Hornblower report. Makary said in an interview on Bloomberg Television’s Wall Street Week with David Westin that companies that promise to equalize prices can receive a “national priority review voucher,” which would cut review times to one to two months. The vouchers are part",
    "url": "https://finnhub.io/api/news?id=39b4cc4c3158480c55ef9d63519eb50223d32ca48c2b944773b35b04bc2e6f03",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752327363,
      "headline": "FDA willing to trade faster drug reviews for lower prices, Bloomberg reports",
      "id": 135899323,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "FDA Commissioner Marty Makary said the agency may fast-track new drugs from pharmaceutical companies that “equalize” the cost of their medicines between the U.S. and other countries, Bloomberg’s Rachel Cohrs Zhang and Sam Hornblower report. Makary said in an interview on Bloomberg Television’s Wall Street Week with David Westin that companies that promise to equalize prices can receive a “national priority review voucher,” which would cut review times to one to two months. The vouchers are part",
      "url": "https://finnhub.io/api/news?id=39b4cc4c3158480c55ef9d63519eb50223d32ca48c2b944773b35b04bc2e6f03"
    }
  }
]